Albumin today is a popular protein that is used for functions such as therapy, diagnosis, and also used as an excipient. The global albumin (excipient) market includes those that are most suited for stabilizing and protecting a drug during its many stages till it is administered. It protects an active pharmaceutical ingredient or a drug against degradations, aggregation, and oxidation. The excipient is present with the drug since the drug’s formulation and protects it during manufacturing, storage, and transportation. An excipient’s feasibility is checked through preformulation studies that check the interactions it has with the intended drug and the environment. An excipient may find vast areas of usability in drug formulation and delivery, along with the manufacture of vaccine and to provide a medium during vaccine production.
Browse Full Global Albumin Market Report With Complete TOC @ http://www.transparencymarketresearch.com/albumin-market.html
Albumin is one of the most popular excipients due to its relatively stable character which makes it easy to handle and store. One of the key advantages of using albumin is its intrinsic stability, due to which it can be heated to 60°C for 10 hours. This facilitates the inactivation of viruses during drug production.
Global Albumin Market Segmentation
The three categories of classifying the global albumin market are applications, type, and geography. By type, the market becomes:
Human Serum Albumin
Bovine Serum Albumin
Human serum albumin held the largest market share in 2013 and was worth US$476.7 million. The bovine serum albumin segment is the second largest, but faces restraining factors mostly concerning ethics. There have been many protests against the alleged cruel treatment of bovine fetuses in the process of obtaining bovine serum. Another restraining factor is the retention of certain amount of impurities in the albumin excipient. The issues with bovine serum...